Continued information about the shortage of the medicinal product Detrunorm XR 30 mg modified release capsules (propiverine)
21.03.2013
Merck, Sharp & Dohme d.o.o., the marketing authorisation holder for the medicinal product Detrunorm XR 30 mg modified release capsules (propiverine), hasd informed the Agency for Medicinal Products and Medical Devices about the shortage of this product on the Croatian market. HALMED reported about this shortage on 31 October 2013 on its webpages. The shortage is due to administrative reasons.
The normalisation of the supply chain with this medicinal product is expected in the third quarter of 2013. The medicinal product Detrunorm 15 mg coated tablets of the same manufacturer not affected by this shortage is available on the Croatian market.
